保險股全線飄紅 中國人壽(601628.SH)漲超3%
格隆匯1月20日丨保險股全線飄紅,中國人壽漲超3%,中國平安、新華保險等紛紛跟漲。

中國人壽發佈公告稱,2019年度歸屬於母公司股東的淨利潤同比預增455.80億元-478.59億元,同增約400%-420%。報告期內,公司推進投資管理體系市場化改革,持續加強資產負債管理,不斷優化資產配置策略,加強基礎資產和戰略資產配置,公司投資收益大幅提升。
對於此次業績增長的原因,中國人壽表示,主要是受投資收益的影響和非經常性損益的影響。2019年,中國人壽推進投資管理體系市場化改革,持續加強資產負債管理,不斷優化資產配置策略,加強基礎資產和戰略資產配置,公司投資收益大幅提升。同時,因執行中國財政部、國家税務總局《關於保險企業手續費及佣金支出税前扣除政策的公告》,公司2018年度應交企業所得税減少約人民幣51.54億元,相應減少本報告期所得税費用。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.